Jane Street
ABCL icon

Jane Street’s AbCellera Biologics ABCL Stock Holding History

Jane Street’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Buy
85,600
+55,000
+180% +$198K ﹤0.01% 9250
2025
Q4 		$105K Buy
30,600
+20,100
+191% +$89.7K ﹤0.01% 10166
2025
Q3 		$52.8K Buy
+10,500
New +$46.3K ﹤0.01% 10335
2024
Q3 		– Sell
-72,400
Closed -$214K – 9479
2024
Q2 		$214K Sell
72,400
-1,900
-3% -$7.19K ﹤0.01% 8284
2024
Q1 		$337K Sell
74,300
-2,300
-3% -$11.7K ﹤0.01% 7369
2023
Q4 		$437K Buy
76,600
+65,100
+566% +$302K ﹤0.01% 6991
2023
Q3 		$52.9K Sell
11,500
-400
-3% -$2.43K ﹤0.01% 8138
2023
Q2 		$76.9K Sell
11,900
-4,400
-27% -$30K ﹤0.01% 8100
2023
Q1 		$123K Buy
16,300
+400
+3% +$3.63K ﹤0.01% 8116
2022
Q4 		$161K Sell
15,900
-102,100
-87% -$1.18M ﹤0.01% 7823
2022
Q3 		$1.17M Sell
118,000
-58,300
-33% -$640K ﹤0.01% 5139
2022
Q2 		$1.88M Buy
176,300
+53,700
+44% +$455K ﹤0.01% 4288
2022
Q1 		$1.2M Sell
122,600
-91,500
-43% -$866K ﹤0.01% 5766
2021
Q4 		$3.06M Buy
214,100
+38,000
+22% +$577K ﹤0.01% 3648
2021
Q3 		$3.53M Buy
176,100
+84,100
+91% +$1.49M ﹤0.01% 3355
2021
Q2 		$2.02M Buy
+92,000
New +$2.54M ﹤0.01% 4317

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's ABCL Position: Q1 2026 in Review

Jane Street reduced its AbCellera Biologics (ABCL) stake by 39% in Q1 2026, selling an estimated $1.98M and leaving 847,883 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #4372.

Jane Street first reported a position in ABCL in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.49M in Q4 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Jane Street held 847,883 shares of AbCellera Biologics worth $2.96M as of Q1 2026.
  • Jane Street sold 549,205 AbCellera Biologics shares in Q1 2026, an estimated $1.98M.
  • AbCellera Biologics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4372 holding.
  • Jane Street first reported a position in AbCellera Biologics in Q4 2020 and has held it in 20 quarters since.
  • Jane Street's AbCellera Biologics position peaked at $5.49M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.